193 related articles for article (PubMed ID: 17560293)
1. Asymmetric dimethylarginine determines the improvement of endothelium-dependent vasodilation by simvastatin: Effect of combination with oral L-arginine.
Böger GI; Rudolph TK; Maas R; Schwedhelm E; Dumbadze E; Bierend A; Benndorf RA; Böger RH
J Am Coll Cardiol; 2007 Jun; 49(23):2274-82. PubMed ID: 17560293
[TBL] [Abstract][Full Text] [Related]
2. Effects of simvastatin and L-arginine on vasodilation, nitric oxide metabolites and endogenous NOS inhibitors in hypercholesterolemic subjects.
Pereira EC; Bertolami MC; Faludi AA; Salem M; Bersch D; Abdalla DS
Free Radic Res; 2003 May; 37(5):529-36. PubMed ID: 12797474
[TBL] [Abstract][Full Text] [Related]
3. Effect of simvastatin on endothelium-dependent vaso-relaxation and endogenous nitric oxide synthase inhibitor.
Jiang JL; Jiang DJ; Tang YH; Li NS; Deng HW; Li YJ
Acta Pharmacol Sin; 2004 Jul; 25(7):893-901. PubMed ID: 15210062
[TBL] [Abstract][Full Text] [Related]
4. Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia.
Lu TM; Ding YA; Leu HB; Yin WH; Sheu WH; Chu KM
Am J Cardiol; 2004 Jul; 94(2):157-61. PubMed ID: 15246890
[TBL] [Abstract][Full Text] [Related]
5. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia.
Böger RH; Bode-Böger SM; Szuba A; Tsao PS; Chan JR; Tangphao O; Blaschke TF; Cooke JP
Circulation; 1998 Nov; 98(18):1842-7. PubMed ID: 9799202
[TBL] [Abstract][Full Text] [Related]
6. Endothelium-dependent vasodilation is independent of the plasma L-arginine/ADMA ratio in men with stable angina: lack of effect of oral L-arginine on endothelial function, oxidative stress and exercise performance.
Walker HA; McGing E; Fisher I; Böger RH; Bode-Böger SM; Jackson G; Ritter JM; Chowienczyk PJ
J Am Coll Cardiol; 2001 Aug; 38(2):499-505. PubMed ID: 11499744
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein.
Beckman JA; Liao JK; Hurley S; Garrett LA; Chui D; Mitra D; Creager MA
Circ Res; 2004 Jul; 95(2):217-23. PubMed ID: 15178637
[TBL] [Abstract][Full Text] [Related]
8. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine.
Thum T; Tsikas D; Stein S; Schultheiss M; Eigenthaler M; Anker SD; Poole-Wilson PA; Ertl G; Bauersachs J
J Am Coll Cardiol; 2005 Nov; 46(9):1693-701. PubMed ID: 16256870
[TBL] [Abstract][Full Text] [Related]
9. Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension.
Perticone F; Sciacqua A; Maio R; Perticone M; Maas R; Boger RH; Tripepi G; Sesti G; Zoccali C
J Am Coll Cardiol; 2005 Aug; 46(3):518-23. PubMed ID: 16053968
[TBL] [Abstract][Full Text] [Related]
10. Asymmetric dimethylarginine (ADMA) elevation and arginase up-regulation contribute to endothelial dysfunction related to insulin resistance in rats and morbidly obese humans.
El Assar M; Angulo J; Santos-Ruiz M; Ruiz de Adana JC; Pindado ML; Sánchez-Ferrer A; Hernández A; Rodríguez-Mañas L
J Physiol; 2016 Jun; 594(11):3045-60. PubMed ID: 26840628
[TBL] [Abstract][Full Text] [Related]
11. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "L-arginine paradox" and acts as a novel cardiovascular risk factor.
Böger RH
J Nutr; 2004 Oct; 134(10 Suppl):2842S-2847S; discussion 2853S. PubMed ID: 15465797
[TBL] [Abstract][Full Text] [Related]
12. Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level.
Jiang JL; Li Ns NS; Li YJ; Deng HW
Br J Pharmacol; 2002 Mar; 135(5):1175-82. PubMed ID: 11877324
[TBL] [Abstract][Full Text] [Related]
13. Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.
Sydow K; Hornig B; Arakawa N; Bode-Böger SM; Tsikas D; Münzel T; Böger RH
Vasc Med; 2004 May; 9(2):93-101. PubMed ID: 15521698
[TBL] [Abstract][Full Text] [Related]
14. Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure.
Feng Q; Lu X; Fortin AJ; Pettersson A; Hedner T; Kline RL; Arnold JM
Cardiovasc Res; 1998 Mar; 37(3):667-75. PubMed ID: 9659450
[TBL] [Abstract][Full Text] [Related]
15. Asymmetrical dimethylarginine plasma concentrations are related to basal nitric oxide release but not endothelium-dependent vasodilation of resistance arteries in peritoneal dialysis patients.
Mittermayer F; Schaller G; Pleiner J; Vychytil A; Sunder-Plassmann G; Hörl WH; Wolzt M
J Am Soc Nephrol; 2005 Jun; 16(6):1832-8. PubMed ID: 15857920
[TBL] [Abstract][Full Text] [Related]
16. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia.
Böger RH; Bode-Böger SM; Sydow K; Heistad DD; Lentz SR
Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1557-64. PubMed ID: 10845872
[TBL] [Abstract][Full Text] [Related]
17. Association of asymmetric dimethylarginine and endothelial dysfunction.
Böger RH
Clin Chem Lab Med; 2003 Nov; 41(11):1467-72. PubMed ID: 14656027
[TBL] [Abstract][Full Text] [Related]
18. A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis.
Laleman W; Omasta A; Van de Casteele M; Zeegers M; Vander Elst I; Van Landeghem L; Severi T; van Pelt J; Roskams T; Fevery J; Nevens F
Hepatology; 2005 Dec; 42(6):1382-90. PubMed ID: 16317694
[TBL] [Abstract][Full Text] [Related]
19. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men.
Adams MR; Forsyth CJ; Jessup W; Robinson J; Celermajer DS
J Am Coll Cardiol; 1995 Oct; 26(4):1054-61. PubMed ID: 7560599
[TBL] [Abstract][Full Text] [Related]
20. Characterization of endothelial factors involved in the vasodilatory effect of simvastatin in aorta and small mesenteric artery of the rat.
Alvarez De Sotomayor M; Herrera MD; Marhuenda E; Andriantsitohaina R
Br J Pharmacol; 2000 Nov; 131(6):1179-87. PubMed ID: 11082126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
